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Abstract
Meningococcal meningitis outbreaks occur every year during the dry season in the ‘‘meningitis belt’’ of sub-Saharan Africa.
Identification of the causative strain is crucial before launching mass vaccination campaigns, to assure use of the correct
vaccine. Rapid agglutination (latex) tests are most commonly available in district-level laboratories at the beginning of the
epidemic season; limitations include a short shelf-life and the need for refrigeration and good technical skills. Recently, a
new dipstick rapid diagnostic test (RDT) was developed to identify and differentiate disease caused by meningococcal
serogroups A, W135, C and Y. We evaluated the diagnostic performance of this dipstick RDT during an urban outbreak of
meningitis caused by N. meningitidis serogroup A in Ouagadougou, Burkina Faso; first against an in-country reference
standard of culture and/or multiplex PCR; and second against culture and/or a highly sensitive nested PCR technique
performed in Oslo, Norway. We included 267 patients with suspected acute bacterial meningitis. Using the in-country
reference standard, 50 samples (19%) were positive. Dipstick RDT sensitivity (N=265) was 70% (95%CI 55–82) and specificity
97% (95%CI 93–99). Using culture and/or nested PCR, 126/259 (49%) samples were positive; dipstick RDT sensitivity
(N=257) was 32% (95%CI 24–41), and specificity was 99% (95%CI 95–100). We found dipstick RDT sensitivity lower than
values reported from (i) assessments under ideal laboratory conditions (.90%), and (ii) a prior field evaluation in Niger [89%
(95%CI 80–95)]. Specificity, however, was similar to (i), and higher than (ii) [62% (95%CI 48–75)]. At this stage in
development, therefore, other tests (e.g., latex) might be preferred for use in peripheral health centres. We highlight the
value of field evaluations for new diagnostic tests, and note relatively low sensitivity of a reference standard using multiplex
vs. nested PCR. Although the former is the current standard for bacterial meningitis surveillance in the meningitis belt,
nested PCR performed in a certified laboratory should be used as an absolute reference when evaluating new diagnostic
tests.
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Introduction
Although most large meningitis epidemics in sub-Saharan
Africa are still caused by Neisseria meningitidis serogroup A [1],
recent meningococcal outbreaks caused by serogroups W135 [2,3]
and X [4,5] underline the importance of serogroup-specific
bacteriological surveillance and outbreak investigation. Several
vaccines with varying serogroup composition are available, and it
is therefore crucial to identify the causative serogroup before
launching reactive mass vaccination campaigns. In addition, the
expected introduction of an affordable conjugate A vaccine in
meningitis belt countries makes meningococcal surveillance crucial
even during inter-epidemic periods [6].
N. meningitidis serogroups can be identified using antisera on
culture, by polymerase chain reaction (PCR), and by latex
agglutination tests such as PastorexH (Bio-Rad Laboratories,
Inc., Marne-la-Coquette, France) on cerebrospinal fluid (CSF).
Culture isolation plus strain serogrouping and PCR-based
methods are generally considered as the reference standard for
identification of N. meningitidis serogroups, since they are highly
specific. Although they necessitate a well-equipped laboratory with
well-trained, specialised technicians, neither of which is often
available close to the outbreak location, CSF samples can be tested
by PCR after transport at ambient temperature in simple dry
tubes, which makes it useful for surveillance in remote areas of
sub-Saharan Africa [7]. If correctly performed on fresh samples
from untreated patients, culture and PCR have been shown to
have comparable performance [8]. Culture-based confirmation,
however, is limited by the low yield of this method, due to a high
susceptibility to contamination, e.g. after specimen preservation or
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treatment [9]. On the other hand, no standardised PCR method
for N. meningitidis detection has yet been established for use in
European or African reference laboratories [9]. Some highly
sensitive methods, such as nested PCR, used in supranational
reference laboratories, are less adapted to field conditions due to
the high probability of contamination, but are helpful as a
reference standard.
Different producers have been developing meningococcal
diagnostic tests better adapted for use in the field. Since 2002,
PastorexH test kits have been made available for the epidemic
seasons in most countries in the meningitis belt, usually at district
level laboratories. This test performs well but requires a minimum
set of equipment (refrigerator, centrifuge and water bath), as the
kit has to be stored at +4uC, and the CSF must be centrifuged and
heated before performing the test [10,11]. The PastorexH test
contains a mixture of anti-W135 and anti-Y reagents, and thus
does not allow differentiation between these two serogroups.
Recently, a new immuno-chromatography dipstick rapid diagnos-
tic test (RDT), for the identification of N. meningitidis serogroups A,
C, Y and W-135, was developed by the Centre de Recherche
Me ´dicale et Sanitaire (CERMES) in Niamey, Niger and the
Pasteur Institute in Paris, France. This dipstick RDT principle is
based on the detection of N. meningitidis serogroup capsular
polysaccharide antigen through a one-step vertical-flow immuno-
chromatography technique [12]. It does not require cold chain for
storage, can be used directly on the CSF and can differentiate
between the four N. meningitidis serogroups using an algorithm
based on the results of two duplex dipsticks [12]. Under ideal
laboratory conditions, the dipstick RDT sensitivity and specificity
have been shown to be both between 93% and 100% [12].
However, during a previous N. meningitidis serogroup A outbreak in
Niger in 2006, the dipstick RDT evaluated in peripheral health
centres showed sensitivity and specificity of 89% and 62%,
respectively [11]. This variation in results, especially the low
specificity observed when the dipstick RDT was conducted in the
field, warranted further evaluation.
Here we report the results of a field evaluation conducted in
March-April 2007 during an N. meningitidis A outbreak in an urban
setting in Ouagadougou, Burkina Faso. We evaluated the new
dipstick RDT in comparison with an in-country reference
standard of culture and/or multiplex PCR. In addition, we
compared dipstick RDT results with those from culture combined
with a highly sensitive nested PCR technique, conducted at the
Meningococcal Reference Laboratory, Norwegian Institute for
Public Health (NIPH) in Oslo, Norway.
Methods
Ethics statement
The study protocol was reviewed and approved by the ethical
committee of the Ministry of Health in Ouagadougou, Burkina
Faso, the Comite ´ de Protection des Personnes, Ile de France XI,
France and the ethics review board of Me ´decins Sans Frontie `res
(MSF). Written consent was obtained from each participating
patient or his/her legal guardian.
Study population and procedures
The study was carried out in Ouagadougou, the capital of
Burkina Faso, after declaration of an epidemic of N. meningitidis
serogroup A in 2007. The study took place at three sites, two
within Pissy district (Pissy Centre Me ´dical avec Antenne
Chirurgicale and Nagrin Centre de Sante ´ et de Promotion Sociale
(CSPS)), while the third site (CSPS Sector 15) fell in a different
health district of Ouagadougou.
From 26 March (week 13) to 21April (week 16) 2007 inclusive,
all patients aged over 2 months presenting at any of the three study
sites with clinically suspected acute bacterial meningitis (see
Appendix S1) [13] and from whom CSF was obtained, were
included in the study. Previous experience has indicated that,
during a meningitis outbreak, the proportion of positive CSF
samples from patients fitting the case definition could be as high as
70% [14,15]. For the sample size calculation, sensitivity was
estimated at 89% (with a precision of 65%) and specificity at 75%
(precision 610%). For an a error of 5%, a sample size of 280 was
needed.
Treatment based on clinical symptoms (not results of the
dipstick RDT being evaluated) was provided free of charge by
MSF, according to the treatment protocol for meningococcal
meningitis [13], and following national guidelines.
According to national guidelines, a lumbar puncture was
performed by a trained nurse on each suspected meningitis
patient. A sample of 3 ml CSF was collected into two sterile tubes.
Tube A, containing 2 ml, was used for (1) macroscopic
examination (appearance of CSF); (2) inoculation of CSF into
trans-isolate (TI) medium for culture (1 ml); (3) performance of
dipstick RDTs at study site (0.5 ml). Tube B, containing 1 ml
CSF, was frozen for future PCR. Data collected for each suspected
meningitis patient included the health centre name, patient’s age,
sex, place of origin, antibiotics/antimalarials already taken (where
appropriate), whether meningitis vaccination was received before
arrival to the health centre, symptoms and clinical signs.
Tests conducted in the field in Burkina Faso
After examination of CSF appearance (cloudy, clear or bloody),
dipstick RDTs were performed following the manufacturers’
instructions by the treating nurse or physician at each of the three
study sites. Briefly, seven drops of CSF were placed in each of two
tubes. The two RDT dipsticks were placed in the tubes and left for
10 to 15 minutes before reading. Interpretation of the test was
completed using the interpretation algorithm, which determines
the serogroup based on the results of both dipsticks [12]. Results
were classified as undefined if one or both of the lines of the RDT
dipsticks were too faint to read.
Tests conducted in the laboratory in Burkina Faso
CSF-inoculated TI media were transported weekly during the
study to the Burkina Faso national reference laboratory, in the
Charles de Gaulle Paediatric Hospital in Ouagadougou, where
culture was performed on chocolate agar plates. Bacteria growing
on these plates were identified using standard bacteriological
techniques. Serogrouping of N. meningitidis was done using specific
N. meningitidis anti-sera [16] (BD Difco
TM).
Frozen CSF samples were first sent to the PCR laboratory at
Centre Muraz/Agence de Me ´decine Pre ´ventive (AMP) in Bobo-
Dioulasso, Burkina Faso. After DNA extraction, an initial
multiplex PCR was performed as described previously [17] using
three pairs of primers for the identification of N. meningitidis,
Streptococcus pneumoniae and Haemophilus influenzae (type b). If a
sample was positive for N. meningitidis, the result was confirmed by
a specific single PCR and a second multiplex PCR for
genogrouping was performed using primers specific for the siaD
and mynB genes [18].
All positive N. meningitidis isolates grown in culture were
transported to the meningococcal unit at the Institut de Me ´decine
Tropicale du Service de Sante ´ des Arme ´es (IMTSSA), the WHO
Collaborating Centre for Reference and Research on Meningo-
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determination (serogroup, serotype and sub-type) by ELISA using
monoclonal antibodies.
Tests conducted in the supranational reference
laboratory in Oslo
Remaining CSF specimens from B tubes were sent to the NIPH
in Oslo. DNA was extracted using a QIAamp DNA mini kit
(QiaGen, Oslo, Norway) according to the manufacturers’
recommendations. Nested PCR was performed as described
previously using primers specific for the porA gene [19]. If the
nested porA PCR was positive, the PCR product was sequenced on
both strands to determine the genosubtype of the infecting strain
and the CSF was subjected to another PCR for genogrouping,
using primers specific for the siaD and mynB genes [18].
Analysis
Data were entered into EpiData 3.0 software (The EpiData
Association, Odense, Denmark) and analysis was conducted using
Stata 8.0 (Stata Corporation, College Station, Texas, USA).
As our analysis focused on the detection of the outbreak strain
(N. meningitidis serogroup A), all results indicating other strains or
serogroups were classified as negative.
We calculated sensitivity, specificity, positive and negative
predictive values (PPV and NPV, respectively) with 95%
confidence intervals (95%CI) for the dipstick RDT, using a
reference standard of culture and/or multiplex PCR in which both
of these tests were conducted at the laboratory in Burkina Faso.
This combination reference standard has been used in prior
evaluations of the RDT [11,12]. Samples with positive results for
either culture or PCR were defined as reference standard positive.
Reference standard negatives were samples with both test results
negative, or those with one test negative and the other either not
done or with an undetermined result. Excluded from analysis were
all samples with the dipstick RDT or both reference standard test
results either missing or undetermined (samples with contaminated
culture, inhibited PCR and undefined RDT results were classified
as having undetermined results). The same performance indicators
were calculated using a second reference standard, in which in-
country culture was combined with nested PCR conducted at the
NIPH in Oslo.
Results
A total of 268 patients fulfilled the inclusion criteria (Figure 1).
Among 228 valid culture results, 43 (19%) were positive for N.
meningitidis A and three (1%) were positive for Streptococcus spp.
Among 253 valid in-country multiplex PCR results, 43 (17%) were
positive for N. meningitidis A, and one (,1%) was positive for S.
pneumoniae. Among 218 valid nested PCR results, 118 (54%) were
positive for N. meningitidis A, and one (,1%) was positive for N.
meningitidis serogroup X. Finally, among 266 valid dipstick RDT
results, 42 (16%) were positive for N. meningitidis A, and two (,1%)
Figure 1. Schematic of all rapid and confirmatory diagnostic tests for Neisseria meningitidis conducted on cerebrospinal fluid (CSF)
samples, showing results obtained for serogroup A. Shaded section shows confirmatory tests (‘reference standard’). (Note: RDT=dipstick
rapid diagnostic test; ‘Uninterpretable’ for CSF appearance=bloody CSF, for culture=contaminated, for PCR=inhibited.)
doi:10.1371/journal.pone.0011086.g001
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samples on which genogrouping was performed, 56 were positive
(46%). Of these, 55 were serogroup A and one was serogroup X
(the remaining samples were positive on nested porA PCR only).
There were 265 CSF samples with either a positive or negative
result for both the dipstick RDT and the in-country reference
standard (Figure 2), from which we found dipstick RDT sensitivity
to be 70% (95%CI 55–82), specificity 97% (95%CI 93–100), PPV
83% (95%CI 69–93) and NPV 93% (95%CI 89–96) (Table 1).
Of the 50 patients with CSF samples positive by the in-country
reference standard and having information on all three classical
clinical signs for meningitis (fever, headache and stiff neck), 18
(36%) had all three. In contrast, only 40 of the 216 (19%) patients
with negative samples by this reference standard had all three
clinical signs present together (x
2 for difference between
proportions=7.3; p=0.007; Table 2). Cloudy CSF was observed
in 31/45 (69%) patients whose samples had been confirmed by this
reference standard, vs 9/204 (4%) of patients for whom this
reference standard was negative (x
2=113.7; p,0.0001; Table 2).
In the comparison with a reference standard of culture and/or
nested PCR (Figure 3), there were 257 CSF samples with a clear
positive or negative result for both tests. We found dipstick RDT
sensitivity to be 32% (95%CI 24–41), specificity 99% (95%CI 95–
100), PPV 95% (95%CI 84–99) and NPV 61% (95%CI 54–67)
(Table 1).
Among patients with positive or negative CSF samples by this
reference standard, 33/125 (26%) and 24/133 (18%), respectively,
had all three classical meningitis signs (x
2=2.6; p=0.11). The
CSF was cloudy in 33/118 (28%) positive samples vs 7/109 (6%)
of negative samples (x
2=18.1; p,0.0001; Table 2).
Of the 268 patients included in the study, 31 (12%) had taken
an antibiotic prior to arrival at the study site, and 190 (71%)
reported having had a meningitis vaccination. Of the 190
previously vaccinated patients, 26/178 (15%) were positive by
the reference standard using culture and/or multiplex PCR, while
82/182 (45%) previously vaccinated patients were positive by the
reference standard which incorporated nested PCR. Vaccination
cards were not observed, so these data were obtained by verbal
confirmation only.
Discussion
Using an in-country reference standard of culture and/or
multiplex PCR, we show that dipstick RDT sensitivity at 70%
(95%CI 55–82) was lower and specificity at 97% (95%CI 93–99)
was substantially higher than found in an earlier dipstick RDT
field evaluation using the same reference standard [89%
(95%CI 80–95) and 62% (95%CI 48–75) respectively] [11].
The dipstick RDT sensitivity found in this study was also lower
than reported from prior evaluations conducted using ideal
laboratory conditions (89%; 95%CI 84–93 [20] and 94%;
95%CI 92–96 [12]). Specificity, however, was comparable to
that found by these studies [94% (95%CI 92–96) [20] and 97%
(95%CI 94–99) [12]].
Variation in dipstick RDT results may be explained by
differences in the test quality, which could be due either to
batch-to-batch performance variations or poor stability of the test.
The latter should be considered especially as dipstick RDT kits
were stored at room temperature, which reached 40uC during the
study. Such variations have been largely documented for other
rapid diagnosis tests, e.g. the malaria RDT using similar
mechanisms [21,22]. Further development of the dipstick RDT
should ensure better and more reproducible results, although the
mass production of this test in the future is not yet assured [23].
Figure 2. Flow diagram showing diagnostic performance of the dipstick rapid diagnostic test (RDT) against a reference standard of
in-country culture and/or multiplex PCR conducted in Burkina Faso. (Note: ‘‘No reference standard’’ indicates those samples for which the
reference standard result was undetermined or where there was not enough CSF remaining to conduct PCR.)
doi:10.1371/journal.pone.0011086.g002
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shown in the current study) indicate that this dipstick RDT should
not be used at bedside for individual patient diagnosis. Conditional
on sufficient batch-to-batch stability, this RDT may be useful to
declare an outbreak, and to guide vaccination choice.
The variations in performance described here suggest that other
rapid tests, such as the latex agglutination tests, are preferable for
use at a peripheral laboratory level, once the necessary equipment
is available. The latter is important, as earlier research emphasises
that the latex agglutination tests must be used according to
manufacturers’ recommendations in order to achieve optimum
sensitivity, requiring a certain level of human resources and
infrastructure [11].
Although culture is known to have a low sensitivity, especially in
cases where antibiotics have been administered to patients or if the
sample collection and/or transportation are sub-optimal [24,25],
this technique remains indispensable to determine the antibiotic
sensitivity profile and genetically characterize the outbreak strain.
PCR is of added value due to its greater yield of valid results in
remote areas, and its capacity to detect and serogroup other agents
of bacterial meningitis, namely pneumococci, Haemophilus influenzae
b and N. meningitidis serogroup X [8,26]. PCR is generally
considered to be more sensitive than culture [23,27], since it can
detect DNA of few dead or alive bacteria. However, previous
studies in sub-Saharan Africa have shown comparable sensitivity
and specificity of culture and PCR if performed on fresh CSF from
untreated patients [8]. This study, therefore, like previous
evaluations of rapid tests for N. meningitidis [11,12,15], used a
reference standard which combined the locally available tech-
niques of culture and mutliplex PCR. A highly sensitive nested
PCR technique was added (also in combination with in-country
culture) as an absolute reference. In a nested PCR, the initial PCR
reaction is performed on the extract and the product of this first
reaction is then used as a template for a second PCR reaction.
While a reference standard including this technique was thus
expected to have a better sensitivity than one incorporating
multiplex PCR (which involved two multiplex and one specific
PCR step), the magnitude of this difference was surprising. As the
laboratory performing the multiplex PCR in this study was a high-
quality national reference laboratory, this difference could be even
higher if it had been performed in regional or district laboratories.
Comparative analysis of the two PCR techniques (data not shown)
revealed that of 118 samples positive for N. Meningitidis serogroup
A by the more sensitive nested PCR technique, only 37 (31%) were
positive by multiplex PCR (there were no additional samples
positive by multiplex PCR, i.e. all samples negative by the nested
technique were also negative by multiplex). Incorporating culture
with the PCR results gave a similar result (48 culture-with-
multiplex PCR out of 126 culture-with-nested PCR positive; 38%).
Although multiplex PCR is the current standard for bacterial
meningitis surveillance in the meningitis belt, the more sensitive
nested PCR technique would provide more accurate information
for evaluation of a new diagnostic test. However, the greater risk of
contamination during the nested PCR is much higher, so this
technique may not be feasible as part of an in-country reference
standard, although samples could be transported to a suprana-
tional reference laboratory certified for this procedure, as was
done in our study. An alternative in-country method could be to
use the PorA gene directly to indicate presence of N. meningitidis,
followed by genogrouping (but should initially be compared with
multiplex PCR).
A comparison study of PCR methods between several European
laboratories has shown that the primers used for PCR identifica-
tion of N. meningitidis give equivalent results [9]. However, this
Table 1. Sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively) for the dipstick RDT* against a
reference standard of culture and/or (a) multiplex PCR and (b) nested PCR.
(a) Dipstick RDT vs culture
and/or multiplex PCR (N=265)
(b) Dipstick RDT vs culture
and/or nested PCR (N=257)
Sensitivity % (95%CI) 70 (55.4–82.1) 32 (23.9–40.9)
Specificity % (95%CI) 97 (93.4–98.7) 99 (94.6–99.8)
PPV % (95%CI) 83 (68.6–93.0) 95 (83.8–99.4)
NPV % (95%CI) 93 (89.1–96.2) 61 (53.6–67.0)
Prevalence 19 (14–24) 49 (42–55)
*RDT: Rapid diagnostic test.
doi:10.1371/journal.pone.0011086.t001
Table 2. Clinical signs and appearance of cerebrospinal fluid (CSF) samples by reference standard result.
Cloudy CSF
appearance (%)
Number with any
one clinical sign* (%)
Number with all
3 clinical signs* (%)
Samples positive by culture
and/or multiplex PCR (N=50)
31/45 (69) 50/50 (100) 18/50 (36)
Samples negative by culture
and/or multiplex PCR (N=217)
9/190 (5) 207/216 (96) 40/216 (19)
Samples positive by culture
and/or nested PCR (N=126)
33/118 (28) 123/125 (98) 33/123 (26)
Samples negative by culture
and/or nested PCR (N=133)
7/109 (6) 127/133 (95) 24/133 (18)
*‘Clinical signs’: the three classic clinical signs for meningitis (fever, headache and stiff neck).
doi:10.1371/journal.pone.0011086.t002
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laboratories, with one laboratory having a sensitivity of only 55%
compared with the consensus results of all laboratories [9]. This
underlines the importance of the type of PCR technique used for
the diagnosis of bacterial meningitis, and the potential for
variation between laboratories.
Apart from these technical considerations, the choice of
laboratory method ultimately depends on how the results are
being used; these may be different if used for (a) clinical diagnosis
at an individual level (bedside), (b) surveillance to detect outbreaks
and to guide vaccine choice, (c) estimating burden of disease
during or outside epidemics, (d) surveillance to describe the
etiological range of bacterial meningitis, or (e) surveillance to
evaluate vaccine impact and strain replacement. This evaluation
shows the value of the dipstick RDT for use in (b).
The dipstick RDT is clearly easier to use and to store, and
requires less training for its users, than any of the prior rapid tests
(such as PastorexH or SlidexH) or the two other tests used in-
country for the reference standard, culture and multiplex PCR.
This advantage for outbreak investigation in remote settings
should be carefully weighed against limitations in performance
identified in the present study. To limit potential harm by
inappropriate treatment decision following a negative dipstick
RDT result, it may be necessary to restrict its use to staff not
involved in routine patient care. Further evaluation of the field
performance of the dipstick RDT in identifying other serogroups is
needed, in particular serogroup W135 (for which a different
vaccine is required). In this analysis, we treated two dipstick RDT
results positive for N. meningitis W135, as negative (i.e. negative for
the outbreak strain). Interestingly, one of these samples was
positive for N. meningitidis A by both PCR techniques, while the
other sample was negative by multiplex PCR (there was
insufficient CSF for nested PCR to be performed). This highlights
the need to investigate the dipstick RDT further for potentially
misleading cross-reactivities.
Finally, although results from evaluations performed in well-
resourced, air-conditioned laboratories with fully trained person-
nel may well be excellent indicators of a new test’s theoretical
optimal performance, they cannot and should not be assumed to
apply equally to the field without thorough ‘operational’ testing,
especially when they are to be used in the hot, dry, dusty areas
with limited resources such as the African meningitis belt. Our
studies illustrate that there is no substitute for ‘real’ field testing in
diagnostics, and prove the value of operational research.
Supporting Information
Appendix S1 Case definition for suspected acute bacterial
meningitis patients used during the study [13].
Found at: doi:10.1371/journal.pone.0011086.s001 (0.03 MB
DOC)
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